Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation

Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation

We assessed the pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children while they were receiving nevirapine-containing fixed-dose combination tablets with rifampicin-based tuberculosis treatment and after discontinuation. The median age (range) was 9.7 (4.4-11.7) years. The nevir...

Saved in:

書目詳細資料
Main Authors:	Wasana Prasitsuebsai, Tim R. Cressey, Edmund Capparelli, Nirun Vanprapar, Keswadee Lapphra, Kulkanya Chokephaibulkit
格式:	雜誌
出版:	2018
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84858800794&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51921
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
由: Wasana Prasitsuebsai, et al.
出版: (2018)

Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
由: Prasitsuebsai W., et al.
出版: (2017)

Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis
由: Weerawat Manosuthi, et al.
出版: (2018)

Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin
由: W. Manosuthi, et al.
出版: (2018)

T-cell subpopulations in tuberculosis and the effects of rifampicin
由: A. Vidhidharm, et al.
出版: (2018)

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine
由: Kulkanya Chokephaibulkit, et al.
出版: (2018)

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine
由: Kulkanya Chokephaibulkit, et al.
出版: (2018)

Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin
由: Weerawat Manosuthi, et al.
出版: (2018)

Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin
由: Weerawat Manosuthi, et al.
出版: (2018)

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
由: Blessed Winston Aruldhas, et al.
出版: (2020)

Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 Weeks results
由: Weerawat Manosuthi, et al.
出版: (2018)

Susceptibility of Rifampicin-Isoniazid Resistant Mycobacterium Tuberculosis Isolates Against Levofloxacin
由: Alvin Hartanto Kurniawan, et al.
出版: (2016)

A case of probable congenital tuberculosis successfully treated with rifampicin and INH
由: N. Kotchabhakdi, et al.
出版: (2018)

Correlation of inflammatory cytokines on corrected QT interval in rifampicin-resistant tuberculosis patients
由: Tutik Kusmiati, Tutik, et al.

Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis
由: S. Foongladda, et al.
出版: (2018)

Development and performance of CUHASROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia
由: Bumi Herman, et al.
出版: (2022)

Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment
由: Mohammed Lamorde, et al.
出版: (2018)

Analysis of RNA polymerase gene mutation in three isolates of rifampicin resistant Mycobacterium tuberculosis.
由: P. Vattanaviboon, et al.
出版: (2018)

Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis
由: Reshma S. Autar, et al.
出版: (2018)

Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens
由: Tutik Kusmiati, Tutik, et al.

Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment
由: Kifayatullah Shah, et al.
出版: (2018)

GeneXpert MTB/RIF and Mycobacterium tuberculosis Sputum Culture in Establishing the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance in Suspected Childhood Pulmonary Tuberculosis in Soetomo Hospital
由: Berlian Beatrix Rarome, -, et al.
出版: (2020)

Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains from Thailand and its evolutionary implication
由: Pongrama Ramasoota, et al.
出版: (2018)

Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial
由: Gurumurthy, Meera, et al.
出版: (2021)

Combined Locked Nucleic Acid Probes and High-Resolution Melting Curve Analysis for Detection of Rifampicin-Resistant Tuberculosis in Northern Thailand
由: Thant Y.M.
出版: (2023)

Optimizing the TRUNCATE strategy to further improve outcomes from two-month treatment for rifampicin-susceptible tuberculosis: Health economics presentation
由: Schaffer, Elisabeth, et al.
出版: (2024)

Artificial neural network for pulmonary rifampicin resistant tuberculosis screening Indonesia : a study in accuracy and cost-effectiveness analysis of the model
由: Bumi Zulheri Herman
出版: (2020)

Factors Predicting Fatigue in Pulmonary Tuberculosis Patients Receiving Anti-Tuberculosis Drugs
由: Wipratchaya Thedthong, et al.
出版: (2022)

Evaluation of rifampicin in the treatment of tuberculous meningitis in children
由: Pongsakdi Visudhiphan, et al.
出版: (2018)

The role of C-Reactive protein as an inflammatory marker to predict prolonged QTc interval in rifampicin-resistant tuberculosis patients: A case-control study
由: Tutik Kusmiati, Tutik, et al.

Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin
由: Weerawat Manosuthi, et al.
出版: (2018)

Comparison of cost-effectiveness between 9 month isoniazid and 2 month rifampicin plus pyrazinamide for prevention to active tuberculosis among people living with HIV Thailand
由: Saiyud Moolphate
出版: (2001)

Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: A four-year prospective study
由: Weerawat Manosuthi, et al.
出版: (2018)

Drug-resistant tuberculosis in children in Thailand
由: K. Lapphra, et al.
出版: (2018)

PERBEDAAN KADAR INTERLEUKIN-6 DAN TUMOR NECROSIS FACTOR-α PLASMA ORANG SEHAT, PENDERITA TUBERKULOSIS PARU RIFAMPICIN RESISTANT DAN RIFAMPICIN SENSITIVE
由: WAHYU SETIANI WIBOWO, NIM011328156302
出版: (2017)

USFDA-GUIDELINEBASED VALIDATION OF TESTING METHODFOR RIFAMPICIN IN INDONESIANSERUM SPECIMEN
由: Perpustakaan UGM, i-lib
出版: (2010)

Report of the pharmacokinetic study of the interaction between rifampicin and mefloquine in humans
由: Wibool Ridtitid, et al.
出版: (2000)

COMPOSITE MANNOSYLATED NANOPARTICLE FORMULA DEVELOPMENT ON RIFAMPICIN DELIVERY SYSTEM
由: Rachmawati, Putriana

ACEMANNAN INCORPORATION INTO NANOSTRUCTURE LIPID CARRIER FOR RIFAMPICIN DELIVERY SYSTEM
由: Rachmawati, Putriana

Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: A 144-week prospective study
由: Weerawat Manosuthi, et al.
出版: (2018)